Intrabone marrow transplantation of unwashed cord blood using reduced-intensity conditioning treatment: A Phase I study

Biology of Blood and Marrow Transplantation

Volumn 18, Issue 4, 2012, Pages 633-639

  Okada, Masaya ^a   Yoshihara, Satoshi ^a   Taniguchi, Kyoko ^a   Kaida, Katsuji ^a   Ikegame, Kazuhiro ^a   Kato, Ruri ^a   Tamaki, Hiroya ^a   Inoue, Takayuki ^a   Soma, Toshihiro ^a   Kai, Shunro ^a   Kato, Shunichi ^b   Ogawa, Hiroyasu ^a  

^a HYOGO COLLEGE OF MEDICINE   (Japan)

^b TOKAI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Cord blood transplantation; Intrabone marrow injection; Reduced intensity conditioning; Unwashed cord blood

Indexed keywords

ACICLOVIR; CYCLOPHOSPHAMIDE; CYCLOSPORIN A; FLUCONAZOLE; FLUDARABINE; GANCICLOVIR; ITRACONAZOLE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; VORICONAZOLE;

ACUTE GRAFT VERSUS HOST DISEASE; ACUTE GRANULOCYTIC LEUKEMIA; ACUTE LYMPHOBLASTIC LEUKEMIA; ADULT; AGED; ARTICLE; BONE MARROW CELL; BONE MARROW TRANSPLANTATION; CELL LOSS; CHIMERA; CHRONIC GRAFT VERSUS HOST DISEASE; CLINICAL ARTICLE; CONTINUOUS INFUSION; ENGRAFTMENT; FEMALE; GRAFT VERSUS HOST REACTION; HUMAN; ILIAC BONE; INTRABONE MARROW TRANSPLANTATION; MALE; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS INFECTION; MYELODYSPLASTIC SYNDROME; NEUTROPHIL; NONHODGKIN LYMPHOMA; PHASE 1 CLINICAL TRIAL; POSTOPERATIVE PAIN; REDUCED INTENSITY CONDITIONING; STEM CELL; SURVIVAL; T LYMPHOCYTE; THROMBOCYTE; THROMBOTIC THROMBOCYTOPENIC PURPURA; TREATMENT OUTCOME; UMBILICAL CORD BLOOD; UNWASHED CORD BLOOD; WHOLE BODY RADIATION;

AGED; BONE MARROW TRANSPLANTATION; CELL COUNT; CORD BLOOD STEM CELL TRANSPLANTATION; DISEASE-FREE SURVIVAL; FEMALE; GRAFT REJECTION; GRAFT VS HOST DISEASE; HISTOCOMPATIBILITY TESTING; HUMANS; INFUSIONS, INTRAOSSEOUS; JAPAN; LEUKEMIA; MALE; MIDDLE AGED; NEUTROPHILS; TRANSPLANTATION CHIMERA; TRANSPLANTATION CONDITIONING; TRANSPLANTATION, HOMOLOGOUS;

EID: 84858081346     PISSN: 10838791     EISSN: 15236536     Source Type: Journal    
DOI: 10.1016/j.bbmt.2011.08.010     Document Type: Article

References (29)

1. Laughlin M.J., Eapen M., Rubinstein P., et al. Outcomes after transplantation of cord blood or bone marrow from unrelated donors in adults with leukemia. N Engl J Med 2004, 351:2265-2275.
2. Rocha V., Labopin M., Sanz G., et al. Transplants of umbilical-cord blood or bone marrow from unrelated donors in adults with acute leukemia. N Engl J Med 2004, 351:2276-2285.
3. Takahashi S., Ooi J., Tomonari A., et al. Comparative single-institute analysis of cord blood transplantation from unrelated donors with bone marrow or peripheral blood stem-cell transplants from related donors in adult patients with hematologic malignancies after myeloablative conditioning regimen. Blood 2007, 109:1322-1330.
4. Okada M., Fujimori Y., Misawa M., et al. Unrelated umbilical cord blood transplantation using a TBI/FLAG conditioning regimen for adults with hematologic malignancies. Biol Blood Marrow Transplant 2008, 14:896-903.
5. Atsuta Y., Suzuki R., Nagamura-Inoue T., et al. Disease-specific analyses of unrelated cord blood transplantation compared with unrelated bone marrow transplantation in adult patients with acute leukemia. Blood 2009, 113:1631-1638.
6. Barker J.N., Weisdorf D.J., DeFor T.E., Blazar B.R., Miller J.S., Wagner J.E. Rapid and complete donor chimerism in adult recipients of unrelated donor umbilical cord blood transplantation after reduced-intensity conditioning. Blood 2003, 102:1915-1919.
7. Chao N.J., Koh L.P., Long G.D., et al. Adult recipients of umbilical cord blood transplants after nonmyeloablative preparative regimens. Biol Blood Marrow Transplant 2004, 10:569-575.
8. Misawa M., Kai S., Okada M., et al. Reduced-intensity conditioning followed by unrelated umbilical cord blood transplantation for advanced hematologic malignancies: rapid engraftment in bone marrow. Int J Hematol 2006, 83:74-79.
9. Uchida N., Wake A., Takagi S., et al. Umbilical cord blood transplantation after reduced-intensity conditioning for elderly patients with hematologic diseases. Biol Blood Marrow Transplant 2008, 14:583-590.
10. - cells assured by intra-bone marrow injection. Blood 2003, 101:2924-2931.
11. Nakamura K., Inaba M., Sugiura K., et al. Enhancement of allogeneic hematopoietic stem cell engraftment and prevention of GVHD by intra-bone marrow bone marrow transplantation plus donor lymphocyte infusion. Stem Cells 2004, 22:125-134.
12. Castello S., Podesta M., Menditto V.G., et al. Intra-bone marrow injection of bone marrow and cord blood cells: an alternative way of transplantation associated with a higher seeding efficiency. Exp Hematol 2004, 32:782-787.
13. van Hennik P.B., de Koning A.E., Ploemacher R.E. Seeding efficiency of primitive human hematopoietic cells in nonobese diabetic/severe combined immune deficiency mice: implications for stem cell frequency assessment. Blood 1999, 94:3055-3061.
14. Cashman J.D., Eaves C.J. High marrow seeding efficiency of human lymphomyeloid repopulating cells in irradiated NOD/SCID mice. Blood 2000, 96:3979-3981.
15. Ogawa H., Ikegame K., Yoshihara S., et al. Unmanipulated HLA 2-3 antigen-mismatched (haploidentical) stem cell transplantation using nonmyeloablative conditioning. Biol Blood Marrow Transplant 2006, 12:1073-1084.
16. Tamaki H., Ikegame K., Kawakami M., et al. Successful engraftment of HLA-haploidentical related transplants using nonmyeloablative conditioning with fludarabine, busulfan and anti-T-lymphocyte globulin. Leukemia 2003, 17:2052-2054.
17. Baron F., Baker J.E., Storb R., et al. Kinetics of engraftment in patients with hematologic malignancies given allogeneic hematopoietic cell transplantation after nonmyeloablative conditioning. Blood 2004, 104:2254-2262.
18. Przepiorka D., Weisdorf D., Martin P., et al. 1994 Consensus conference on acute GVHD grading. Bone Marrow Transplant 1995, 15:825-828.
19. Ogawa H., Tamaki H., Ikegame K., et al. The usefulness of monitoring WT1 gene transcripts for the prediction and management of relapse following allogeneic stem cell transplantation in acute type leukemia. Blood 2003, 101:1698-1704.
20. Frassoni F., Gualandi F., Podesta M., et al. Direct intrabone transplant of unrelated cord-blood cells in acute leukaemia: a phase I/II study. Lancet Oncol 2008, 9:831-839.
21. Frassoni F., Varaldo R., Gualandi F., et al. The intra-bone marrow injection of cord blood cells extends the possibility of transplantation to the majority of patients with malignant hematopoietic diseases. Best Pract Res Clin Haematol 2010, 23:237-244.
22. Brunstein C.G., Barker J.N., Weisdorf D.J., et al. Intra-BM injection to enhance engraftment after myeloablative umbilical cord blood transplantation with two partially HLA-matched units. Bone Marrow Transplant 2009, 43:935-940.
23. Ramirez P.A., Wagner J.E., Brunstein C.G. Going straight to the point: intra-BM injection of hematopoietic progenitors. Bone Marrow Transplant 2010, 45:1127-1133.
24. Rubinstein P., Dobrila L., Rosenfield R.E., et al. Processing and cryopreservation of placental/umbilical cord blood for unrelated bone marrow reconstitution. Proc Natl Acad Sci USA 1995, 92:10119-10122.
25. Davis J.M., Rowley S.D., Braine H.G., Piantadosi S., Santos G.W. Clinical toxicity of cryopreserved bone marrow graft infusion. Blood 1990, 75:781-786.
26. Beaujean F., Hartmann O., Kuentz M., Le Forestier C., Divine M., Duedari N. A simple, efficient washing procedure for cryopreserved human hematopoietic stem cells prior to reinfusion. Bone Marrow Transplant 1991, 8:291-294.
27. Barker J.N., Abboud M., Rice R.D., et al. A " no-wash" albumin-dextran dilution strategy for cord blood unit thaw: high rate of engraftment and a low incidence of serious infusion reactions. Biol Blood Marrow Transplant 2009, 15:1596-1602.
28. Miyakoshi S., Yuji K., Kami M., et al. Successful engraftment after reduced-intensity umbilical cord blood transplantation for adult patients with advanced hematological diseases. Clin Cancer Res 2004, 10:3586-3592.
29. Feng Q., Chow P.K., Frassoni F., et al. Nonhuman primate allogeneic hematopoietic stem cell transplantation by intraosseus vs intravenous injection: Engraftment, donor cell distribution, and mechanistic basis. Exp Hematol 2008, 36:1556-1566.